Clinical outcomes and genotype-phenotype correlations in patients with complete and partial androgen insensitivity syndromes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Androgen insensitivity syndrome (AIS) is a rare X-linked recessive disorder caused by unresponsiveness to androgens because of mutations in the AR gene. Here, we investigated the clinical outcomes and molecular spectrum of AR variants in patients with AIS attending a single academic center. Methods: This study included 19 patients with AIS who were confirmed by molecular analysis of AR. Clinical features and endocrinological findings were retrospectively collected, including presenting features, external genitalia, sex of rearing, timing of gonadectomy, pubertal outcomes, and sex hormone levels. Molecular analysis of AR was performed using Sanger, targeted gene panel, or whole-exome sequencing. Results: Among all 19 patients, 14 (74%) were classified as having complete AIS (CAIS), whereas 5 (26%) had partial AIS (PAIS). All patients with CAIS, and 3 patients with PAIS were reared as female. One patient with CAIS manifested a mixed germ cell tumor at the age of 30 years. Molecular analysis of AR identified 19 sequence variants; 12 (63%) were previously reported, and the remaining 7 (37%) were novel. Missense mutations were the most common type (12 of 19, 63%), followed by small deletions, nonsense mutations, an insertion, and a splice site mutation. Conclusion: Here, we describe the clinical outcomes and molecular characteristics of 19 Korean patients with AIS. Patients with PAIS manifested various degrees of masculinization of the external genitalia. Nonsense and frameshift mutations were frequent in patients with CAIS, whereas patients with PAIS harbored exclusively missense mutations.
Abstract
Purpose: Androgen insensitivity syndrome (AIS) is a rare X-linked recessive disorder caused by unresponsiveness to androgens because of mutations in the AR gene. Here, we investigated the clinical outcomes and molecular spectrum of AR variants in patients with AIS attending a single academic center. Methods: This study included 19 patients with AIS who were confirmed by molecular analysis of AR. Clinical features and endocrinological findings were retrospectively collected, including presenting features, external genitalia, sex of rearing, timing of gonadectomy, pubertal outcomes, and sex hormone levels. Molecular analysis of AR was performed using Sanger, targeted gene panel, or whole-exome sequencing. Results: Among all 19 patients, 14 (74%) were classified as having complete AIS (CAIS), whereas 5 (26%) had partial AIS (PAIS). All patients with CAIS, and 3 patients with PAIS were reared as female. One patient with CAIS manifested a mixed germ cell tumor at the age of 30 years. Molecular analysis of AR identified 19 sequence variants; 12 (63%) were previously reported, and the remaining 7 (37%) were novel. Missense mutations were the most common type (12 of 19, 63%), followed by small deletions, nonsense mutations, an insertion, and a splice site mutation. Conclusion: Here, we describe the clinical outcomes and molecular characteristics of 19 Korean patients with AIS. Patients with PAIS manifested various degrees of masculinization of the external genitalia. Nonsense and frameshift mutations were frequent in patients with CAIS, whereas patients with PAIS harbored exclusively missense mutations.
참고문헌 (41)
- Hornig NC, "Molecular basis of androgen insensitivity syndromes", Mol Cell Endocrinol, 523, pp.111146~ (2021)
- Hughes IA, "Androgen insensitivity syndrome", Lancet, 380, pp.1419~1428 (2012)
- Bertelloni S, "Hormonal management of complete androgen insensitivity syndrome from adolescence onward", Horm Res Paediatr, 76, pp.428~433 (2011)
- Boehmer AL, "Genotype versus phenotype in families with androgen insensitivity syndrome", J Clin Endocrinol Metab, 86, pp.4151~4160 (2001)
- Yong EL, "Androgen receptor gene and male infertility", Hum Reprod Update, 9, pp.1~7 (2003)
- Chang CY, "Evaluation of ligand-dependent changes in AR structure using peptide probes", Mol Endocrinol, 16, pp.647~660 (2002)
- Gottlieb B, "The androgen receptor gene mutations database : 2012update", Hum Mutat, 33, pp.887~894 (2012)
- Batista RL, "Androgen insensitivity syndrome : a review", Arch Endocrinol Metab, 62, pp.227~235 (2018)
- 허유정, "Two Korean girls with complete androgen insensitivity syndrome diagnosed in infancy", Annals of Pediatric Endocrinology & Metabolism, 23(4), pp.220~225 (2018), 대한소아내분비학회
- 이성원, "Partial Androgen Insensitivity Syndrome Presenting with Gynecomastia", Endocrinology and Metabolism, 30(2), pp.226~230 (2015), 대한내분비학회
- 이경희, "악성혼합성선세포종양을 동반한 완전 안드로겐 무감응증후군 1예", Obstetrics & Gynecology Science, 54(11), pp.701~706 (2011), 대한산부인과학회
- Choi JH, "Molecular analysis of the AR and SRD5A2 genes in patients with 46, XY disorders of sex development", J Pediatr Endocrinol Metab, 21, pp.545~553 (2008)
- Kim JH, "Diagnostic yield of targeted gene panel sequencing to identify the genetic etiology of disorders of sex development", Mol Cell Endocrinol, 444, pp.19~25 (2017)
- Choi JH, "Molecular characteristics of sequence variants in GATA4 in Patients with 46, XY disorders of sex development without cardiac defects", Sex Dev, 13, pp.240~245 (2019)
- 김재현, "The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects", Clinical and Experimental Pediatrics, 61(5), pp.135~149 (2018), 대한소아청소년과학회
- Marshall WA, "Variations in the pattern of pubertal changes in boys", Arch Dis Child, 45, pp.13~23 (1970)
- Ahmed SF, "The role of a clinical score in the assessment of ambiguous genitalia", BJU Int, 85, pp.120~124 (2000)
- Ahmed SF, "Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development(Revised 2015)", Clin Endocrinol, 84, pp.771~788 (2016)
- McLaren W, "The ensembl variant effect predictor", Genome Biol, 17, pp.122~ (2016)
- Liu X, "dbNSFP v3. 0 : a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs", Hum Mutat, 37, pp.235~241 (2016)
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
- Patel V, "Timing of gonadectomy in patients with complete androgen insensitivity syndromecurrent recommendations and future directions", J Pediatr Adolesc Gynecol, 29, pp.320~325 (2016)
- Hannema SE, "Testicular development in the complete androgen insensitivity syndrome", J Pathol, 208, pp.518~527 (2006)
- Cools M, "Germ cell tumors in the intersex gonad : old paths, new directions, moving frontiers", Endocr Rev, 27, pp.468~484 (2006)
- Hughes IA, "Consensus statement on management of intersex disorders", Arch Dis Child, 91, pp.554~563 (2006)
- Deans R, "Timing of gonadectomy in adult women with complete androgen insensitivity syndrome(CAIS) : patient preferences and clinical evidence", Clin Endocrinol, 76, pp.894~898 (2012)
- Cools M, "Managing the risk of germ cell tumourigenesis in disorders of sex development patients", Endocr Dev, 27, pp.185~196 (2014)
- Barros Beatriz Amstalden, "Complete androgen insensitivity syndrome and risk of gonadal malignancy: systematic review", Annals of Pediatric Endocrinology & Metabolism, 26(1), pp.19~23 (2021), 대한소아내분비학회[DOI]
- Lucas-Herald A, "The long-term outcome of boys With partial androgen insensitivity syndrome and a mutation in the androgen receptor gene", J Clin Endocrinol Metab, 101, pp.3959~3967 (2016)
- Gottlieb B, "Variable expressivity and mutation databases : The androgen receptor gene mutations database", Hum Mutat, 17, pp.382~388 (2001)
- 남효은, "Polycystic ovary syndrome woman with heterozygous androgen receptor gene mutation who gave birth to a child with androgen insensitivity syndrome", Obstetrics & Gynecology Science, 58(2), pp.179~182 (2015), 대한산부인과학회[DOI]
- Wang F, "Alternative splicing of the androgen receptor in polycystic ovary syndrome", Proc Natl Acad Sci U S A, 112, pp.4743~4748 (2015)
- Peng CY, "The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome : a casecontrol study and meta-analysis", J Assist Reprod Genet, 31, pp.1211~1219 (2014)
- Li Y, "A novel mutation of the androgen receptor gene in familial complete androgen insensitivity syndrome", Eur Rev Med Pharmacol Sci, 19, pp.4146~4152 (2015)
- Deeb A, "Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome", Clin Endocrinol, 63, pp.56~62 (2005)
- Beitel LK, "Complete androgen insensitivity due to mutations in the probable alpha-helical segments of the DNA-binding domain in the human androgen receptor", Hum Mol Genet, 3, pp.21~27 (1994)
- Hiort O, "The clinical and molecular spectrum of androgen insensitivity syndromes", Am J Med Genet, 63, pp.218~222 (1996)
- Wang M, "Dissecting phenotypic variation among AIS patients", Biochem Biophys Res Commun, 335, pp.335~342 (2005)
- Audi L, "Novel(60%)and recurrent(40%)androgen receptor gene mutations in a series of 59patients with a 46, XY disorder of sex development", J Clin Endocrinol Metab, 95, pp.1876~1888 (2010)
- Kohler B, "Androgen insensitivity syndrome : somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling", J Clin Endocrinol Metab, 90, pp.106~111 (2005)
- Galani A, "Sex-reversed phenotype in association with two novel mutations c. 2494delA and c. T3004C in the ligand-binding domain of the androgen receptor gene", Fertil Steril, 90, pp.2008~ (2008)